These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

392 related items for PubMed ID: 27794399

  • 1. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
    Lam SK, Leung LL, Li YY, Zheng CY, Ho JC.
    Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
    [Abstract] [Full Text] [Related]

  • 2. Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma.
    Lam SK, Li YY, Zheng CY, Ho JC.
    Int J Oncol; 2015 Jan; 46(1):113-22. PubMed ID: 25335113
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of thymidylate synthase with arsenic trioxide in lung adenocarcinoma.
    Lam SK, Mak JC, Zheng CY, Li YY, Kwong YL, Ho JC.
    Int J Oncol; 2014 Jun; 44(6):2093-102. PubMed ID: 24691991
    [Abstract] [Full Text] [Related]

  • 4. E2F1 downregulation by arsenic trioxide in lung adenocarcinoma.
    Lam SK, Li YY, Zheng CY, Leung LL, Ho JC.
    Int J Oncol; 2014 Nov; 45(5):2033-43. PubMed ID: 25174355
    [Abstract] [Full Text] [Related]

  • 5. Tumour growth-suppressive effect of arsenic trioxide in squamous cell lung carcinoma.
    Leung LL, Lam SK, Li YY, Ho JC.
    Oncol Lett; 2017 Sep; 14(3):3748-3754. PubMed ID: 28927142
    [Abstract] [Full Text] [Related]

  • 6. Combination of arsenic trioxide and chemotherapy in small cell lung cancer.
    Zheng CY, Lam SK, Li YY, Fong BM, Mak JC, Ho JC.
    Lung Cancer; 2013 Nov; 82(2):222-30. PubMed ID: 24041618
    [Abstract] [Full Text] [Related]

  • 7. Co-active receptor tyrosine kinases mitigate the effect of FGFR inhibitors in FGFR1-amplified lung cancers with low FGFR1 protein expression.
    Kotani H, Ebi H, Kitai H, Nanjo S, Kita K, Huynh TG, Ooi A, Faber AC, Mino-Kenudson M, Yano S.
    Oncogene; 2016 Jul 07; 35(27):3587-97. PubMed ID: 26549034
    [Abstract] [Full Text] [Related]

  • 8. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
    Chien CW, Yao JH, Chang SY, Lee PC, Lee TC.
    Toxicol Appl Pharmacol; 2011 Nov 15; 257(1):59-66. PubMed ID: 21889949
    [Abstract] [Full Text] [Related]

  • 9. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
    Shen L, Zhang G, Lou Z, Xu G, Zhang G.
    BMC Complement Altern Med; 2017 Feb 10; 17(1):106. PubMed ID: 28187727
    [Abstract] [Full Text] [Related]

  • 10. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models.
    Zhang J, Zhang L, Su X, Li M, Xie L, Malchers F, Fan S, Yin X, Xu Y, Liu K, Dong Z, Zhu G, Qian Z, Tang L, Schöttle J, Zhan P, Ji Q, Kilgour E, Smith PD, Brooks AN, Thomas RK, Gavine PR.
    Clin Cancer Res; 2012 Dec 15; 18(24):6658-67. PubMed ID: 23082000
    [Abstract] [Full Text] [Related]

  • 11. FGFR1 signaling potentiates tumor growth and predicts poor prognosis in esophageal squamous cell carcinoma patients.
    Chen B, Liu S, Gan L, Wang J, Hu B, Xu H, Tong R, Yang H, Cristina I, Xue J, Hu X, Lu Y.
    Cancer Biol Ther; 2018 Jan 02; 19(1):76-86. PubMed ID: 29257923
    [Abstract] [Full Text] [Related]

  • 12. Honokiol induces apoptosis of lung squamous cell carcinoma by targeting FGF2-FGFR1 autocrine loop.
    Cen M, Yao Y, Cui L, Yang G, Lu G, Fang L, Bao Z, Zhou J.
    Cancer Med; 2018 Dec 02; 7(12):6205-6218. PubMed ID: 30515999
    [Abstract] [Full Text] [Related]

  • 13. Icariin synergizes with arsenic trioxide to suppress human hepatocellular carcinoma.
    Li W, Wang M, Wang L, Ji S, Zhang J, Zhang C.
    Cell Biochem Biophys; 2014 Mar 02; 68(2):427-36. PubMed ID: 23975599
    [Abstract] [Full Text] [Related]

  • 14. Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer.
    Weiss J, Sos ML, Seidel D, Peifer M, Zander T, Heuckmann JM, Ullrich RT, Menon R, Maier S, Soltermann A, Moch H, Wagener P, Fischer F, Heynck S, Koker M, Schöttle J, Leenders F, Gabler F, Dabow I, Querings S, Heukamp LC, Balke-Want H, Ansén S, Rauh D, Baessmann I, Altmüller J, Wainer Z, Conron M, Wright G, Russell P, Solomon B, Brambilla E, Brambilla C, Lorimier P, Sollberg S, Brustugun OT, Engel-Riedel W, Ludwig C, Petersen I, Sänger J, Clement J, Groen H, Timens W, Sietsma H, Thunnissen E, Smit E, Heideman D, Cappuzzo F, Ligorio C, Damiani S, Hallek M, Beroukhim R, Pao W, Klebl B, Baumann M, Buettner R, Ernestus K, Stoelben E, Wolf J, Nürnberg P, Perner S, Thomas RK.
    Sci Transl Med; 2010 Dec 15; 2(62):62ra93. PubMed ID: 21160078
    [Abstract] [Full Text] [Related]

  • 15. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.
    Wang W, Adachi M, Zhang R, Zhou J, Zhu D.
    Pancreas; 2009 May 15; 38(4):e114-23. PubMed ID: 19342982
    [Abstract] [Full Text] [Related]

  • 16. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
    Lai SW, Bamodu OA, Tsai WC, Chang YM, Lee WH, Yeh CT, Chao TY.
    Clin Exp Metastasis; 2018 Oct 15; 35(7):663-677. PubMed ID: 29987671
    [Abstract] [Full Text] [Related]

  • 17. [Experimental study of the anti-tumor effect of arsenic trioxide or thalidomide alone and combination of both for treatment of myelodysplastic syndrome model].
    Lu J, Jin J, Xu WL.
    Zhonghua Er Ke Za Zhi; 2006 Mar 15; 44(3):228-33. PubMed ID: 16624066
    [Abstract] [Full Text] [Related]

  • 18. Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin.
    Chiu HW, Ho YS, Wang YJ.
    J Mol Med (Berl); 2011 Sep 15; 89(9):927-41. PubMed ID: 21594580
    [Abstract] [Full Text] [Related]

  • 19. Arsenic trioxide induces programmed cell death through stimulation of ER stress and inhibition of the ubiquitin-proteasome system in human sarcoma cells.
    Chiu HW, Tseng YC, Hsu YH, Lin YF, Foo NP, Guo HR, Wang YJ.
    Cancer Lett; 2015 Jan 28; 356(2 Pt B):762-72. PubMed ID: 25449439
    [Abstract] [Full Text] [Related]

  • 20. Arsenic trioxide-induced cytotoxicity in small cell lung cancer via altered redox homeostasis and mitochondrial integrity.
    Zheng CY, Lam SK, Li YY, Ho JC.
    Int J Oncol; 2015 Mar 28; 46(3):1067-78. PubMed ID: 25572414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.